Covidien Acquires Reverse Medical
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 22, 2014-- Covidien plc (NYSE:COV) today announced it has acquired Reverse Medical Corporation, a privately held medical device company focused on expanding the management of vascular disease. Financial terms of the transaction were not disclosed.
“Covidien is focused on technologies that deliver improved patient care through clinically relevant and economically valuable solutions,” said Brett Wall, president, Neurovascular, Covidien. “The acquisition of Reverse Medical is complementary to our existing portfolio and will allow us to leverage existing vascular technologies to compete in the worldwide vascular embolization market, which is growing at a double digit rate.”
Reverse Medical is an Irvine, California-based company that was focused on devices to treat endovascular disease. Early Stage Partners Managing Director Mike Bunker led the investment in Reverse. Read more...
Find Out More About ESP
Mike Bunker led the ESP investment in Reverse Medical